| 4.0 |
11.9 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 3.6 |
10.9 |
GO:0070445 |
Fc receptor mediated stimulatory signaling pathway(GO:0002431) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 3.6 |
14.5 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 3.2 |
12.8 |
GO:1904037 |
positive regulation of epithelial cell apoptotic process(GO:1904037) positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 1.9 |
13.1 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
| 1.6 |
4.7 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.5 |
4.5 |
GO:0060557 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
| 1.4 |
10.0 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.2 |
3.5 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 1.1 |
6.7 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 1.0 |
7.0 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 1.0 |
4.0 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.0 |
1.0 |
GO:0046449 |
allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.9 |
16.6 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.9 |
1.8 |
GO:1904035 |
endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) negative regulation of epithelial cell apoptotic process(GO:1904036) regulation of endothelial cell apoptotic process(GO:2000351) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.8 |
10.9 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.8 |
5.7 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.7 |
3.7 |
GO:0010957 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.7 |
2.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.7 |
2.1 |
GO:0060178 |
exocyst assembly(GO:0001927) regulation of exocyst assembly(GO:0001928) exocyst localization(GO:0051601) regulation of exocyst localization(GO:0060178) |
| 0.7 |
4.2 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.7 |
4.8 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.6 |
1.9 |
GO:0050983 |
spermidine catabolic process(GO:0046203) deoxyhypusine biosynthetic process from spermidine(GO:0050983) |
| 0.6 |
3.0 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.6 |
2.9 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.6 |
1.7 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.6 |
10.3 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.6 |
2.3 |
GO:0001807 |
type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.5 |
3.1 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.5 |
1.0 |
GO:0070483 |
detection of hypoxia(GO:0070483) |
| 0.5 |
5.0 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.5 |
31.4 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.5 |
3.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.5 |
0.5 |
GO:0051447 |
tyrosine phosphorylation of Stat1 protein(GO:0042508) negative regulation of meiotic nuclear division(GO:0045835) negative regulation of meiotic cell cycle(GO:0051447) |
| 0.4 |
1.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 |
4.7 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.4 |
1.3 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) positive regulation by host of viral transcription(GO:0043923) modulation by host of symbiont transcription(GO:0052472) |
| 0.4 |
4.4 |
GO:0045885 |
obsolete positive regulation of survival gene product expression(GO:0045885) |
| 0.4 |
4.4 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.4 |
1.6 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.4 |
1.1 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.4 |
1.1 |
GO:0060547 |
negative regulation of necrotic cell death(GO:0060547) |
| 0.4 |
14.0 |
GO:0002286 |
T cell activation involved in immune response(GO:0002286) |
| 0.4 |
8.8 |
GO:0042531 |
positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.4 |
9.8 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.4 |
1.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.3 |
4.1 |
GO:0002639 |
positive regulation of immunoglobulin production(GO:0002639) |
| 0.3 |
2.7 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
| 0.3 |
1.0 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.3 |
2.6 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.3 |
1.6 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.3 |
2.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
1.8 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.3 |
0.9 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.3 |
5.0 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.3 |
1.1 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.3 |
0.8 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 0.3 |
1.4 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.3 |
0.8 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.3 |
0.3 |
GO:0010224 |
response to UV-B(GO:0010224) |
| 0.3 |
1.0 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.3 |
1.8 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.7 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.2 |
0.7 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.2 |
1.0 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.2 |
2.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.2 |
0.7 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
14.7 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.2 |
3.8 |
GO:0045069 |
regulation of viral genome replication(GO:0045069) |
| 0.2 |
2.3 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
0.2 |
GO:0044843 |
G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
| 0.2 |
0.6 |
GO:1904742 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.2 |
1.5 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
0.6 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.2 |
0.8 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 |
0.6 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.2 |
0.5 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
0.2 |
GO:0032754 |
positive regulation of interleukin-5 production(GO:0032754) |
| 0.2 |
1.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.2 |
3.2 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.2 |
0.7 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.2 |
7.4 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.2 |
1.2 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.2 |
2.3 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.2 |
19.5 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.1 |
14.9 |
GO:0007162 |
negative regulation of cell adhesion(GO:0007162) |
| 0.1 |
0.6 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.1 |
0.6 |
GO:0031635 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
2.8 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.1 |
15.3 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.1 |
0.8 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.7 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.1 |
1.9 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.8 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.1 |
1.9 |
GO:0010042 |
response to manganese ion(GO:0010042) |
| 0.1 |
1.7 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
0.5 |
GO:0021759 |
globus pallidus development(GO:0021759) forebrain dorsal/ventral pattern formation(GO:0021798) menarche(GO:0042696) |
| 0.1 |
7.6 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
0.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
1.9 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 |
0.4 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
1.2 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.1 |
0.6 |
GO:0042637 |
catagen(GO:0042637) |
| 0.1 |
0.6 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 |
0.3 |
GO:0000917 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
| 0.1 |
6.9 |
GO:0061025 |
membrane fusion(GO:0061025) |
| 0.1 |
4.0 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 |
1.6 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 |
1.5 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
0.5 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.1 |
1.0 |
GO:0070664 |
negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
| 0.1 |
0.2 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.3 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
1.0 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 |
0.5 |
GO:0002707 |
negative regulation of lymphocyte mediated immunity(GO:0002707) |
| 0.1 |
1.5 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
2.7 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.1 |
0.3 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
7.8 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.1 |
1.2 |
GO:0032876 |
regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
| 0.1 |
1.7 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
1.0 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.9 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.1 |
0.4 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
2.0 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.1 |
0.6 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.1 |
0.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.7 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
0.4 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.3 |
GO:0002860 |
natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.1 |
1.1 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
1.4 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.1 |
0.6 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
| 0.1 |
0.9 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
1.0 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.2 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.1 |
1.0 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
1.0 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
2.2 |
GO:0033572 |
ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.1 |
8.2 |
GO:0006865 |
amino acid transport(GO:0006865) |
| 0.1 |
0.1 |
GO:1902170 |
cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
| 0.1 |
1.2 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
1.5 |
GO:0042098 |
T cell proliferation(GO:0042098) |
| 0.1 |
1.6 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
0.7 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.1 |
0.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
1.1 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
1.9 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.1 |
3.1 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.3 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
2.6 |
GO:0045727 |
positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
| 0.1 |
0.3 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.1 |
0.4 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
0.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
1.1 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.0 |
0.2 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
1.3 |
GO:0051899 |
membrane depolarization(GO:0051899) |
| 0.0 |
0.9 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.8 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.0 |
0.9 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
1.9 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.7 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.6 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.6 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
| 0.0 |
0.8 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.9 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 |
0.2 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) glycosylceramide catabolic process(GO:0046477) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.0 |
0.8 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.0 |
0.4 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.0 |
0.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.3 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
1.4 |
GO:0001503 |
ossification(GO:0001503) |
| 0.0 |
0.1 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 0.0 |
0.3 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 |
0.4 |
GO:1903523 |
negative regulation of blood circulation(GO:1903523) |
| 0.0 |
0.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
1.2 |
GO:0001756 |
somitogenesis(GO:0001756) somite development(GO:0061053) |
| 0.0 |
0.3 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.0 |
3.7 |
GO:0007204 |
positive regulation of cytosolic calcium ion concentration(GO:0007204) |
| 0.0 |
1.1 |
GO:0000080 |
mitotic G1 phase(GO:0000080) |
| 0.0 |
1.4 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.0 |
1.3 |
GO:0046134 |
pyrimidine nucleobase metabolic process(GO:0006206) pyrimidine nucleoside biosynthetic process(GO:0046134) |
| 0.0 |
0.1 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 |
6.6 |
GO:0016337 |
single organismal cell-cell adhesion(GO:0016337) |
| 0.0 |
0.6 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.0 |
0.2 |
GO:0001821 |
histamine secretion(GO:0001821) histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.1 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
0.2 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
1.4 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.0 |
0.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.8 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.7 |
GO:0070588 |
calcium ion transmembrane transport(GO:0070588) |
| 0.0 |
0.4 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.0 |
0.7 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 |
2.0 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.0 |
1.0 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.0 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.0 |
3.3 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.6 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.0 |
0.4 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.1 |
GO:0043628 |
ncRNA 3'-end processing(GO:0043628) |
| 0.0 |
0.5 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.4 |
GO:0021879 |
forebrain neuron differentiation(GO:0021879) |
| 0.0 |
0.9 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.2 |
GO:0035196 |
production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
| 0.0 |
0.5 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
5.3 |
GO:0008015 |
circulatory system process(GO:0003013) blood circulation(GO:0008015) |
| 0.0 |
0.8 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.4 |
GO:0034249 |
negative regulation of translation(GO:0017148) negative regulation of cellular amide metabolic process(GO:0034249) |
| 0.0 |
0.4 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.2 |
GO:0044819 |
mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 |
0.2 |
GO:0033673 |
negative regulation of kinase activity(GO:0033673) |
| 0.0 |
0.3 |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.0 |
0.4 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.1 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.0 |
0.5 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.0 |
0.4 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.4 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.5 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
2.4 |
GO:0023014 |
MAPK cascade(GO:0000165) signal transduction by protein phosphorylation(GO:0023014) |
| 0.0 |
1.0 |
GO:0051781 |
positive regulation of cell division(GO:0051781) |
| 0.0 |
0.1 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 |
0.0 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.5 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 |
0.9 |
GO:0007605 |
sensory perception of sound(GO:0007605) |
| 0.0 |
1.1 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
1.0 |
GO:0006986 |
response to unfolded protein(GO:0006986) |
| 0.0 |
0.6 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 |
0.3 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.6 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.0 |
0.2 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.0 |
0.9 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.0 |
0.6 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 |
0.5 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.3 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.0 |
0.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.2 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.2 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.1 |
GO:0007389 |
pattern specification process(GO:0007389) |
